01:18 AM EDT, 10/28/2026 (MT Newswires) -- AlzeCure Pharma (ALZCUR.ST) named Chief Scientific Officer Johan Sandin as acting chief executive officer, effective Tuesday, according to a same-day release. Sandin's appointment follows the planned departure of CEO Martin Jönsson, the Swedish biotech company said. The search process for a permanent successor will be launched. Meanwhile, head of discovery and research Pontus Forsell will assume the deputy CEO role.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.